ADVENT CAPITAL MANAGEMENT /DE/ - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 2 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ADVENT CAPITAL MANAGEMENT /DE/ ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2021$31,819,000
-14.1%
29,135,000
-15.2%
0.54%
-21.9%
Q3 2021$37,048,000
+0.5%
34,364,000
-4.7%
0.68%
-4.5%
Q2 2021$36,873,000
+29.5%
36,073,000
+27.2%
0.72%
+16.8%
Q1 2021$28,480,000
+33.5%
28,350,000
+33.1%
0.61%
+34.9%
Q4 2020$21,328,000
-1.5%
21,293,000
-5.4%
0.46%
-4.8%
Q3 2020$21,647,000
-8.5%
22,500,000
-5.5%
0.48%
-13.7%
Q2 2020$23,646,000
-29.7%
23,801,000
-34.2%
0.55%
-24.2%
Q1 2020$33,613,000
-6.5%
36,159,000
+1.7%
0.73%
+5.0%
Q4 2019$35,953,000
+8.4%
35,565,000
+1.2%
0.70%
+12.1%
Q3 2019$33,156,000
-10.0%
35,150,000
+0.3%
0.62%
-12.9%
Q2 2019$36,824,000
+8.4%
35,038,000
+4.4%
0.71%
-4.8%
Q1 2019$33,962,000
-8.9%
33,576,000
-2.3%
0.75%
-16.9%
Q4 2018$37,269,000
-2.5%
34,364,000
-8.3%
0.90%
+14.3%
Q3 2018$38,239,000
+204.7%
37,486,000
+188.4%
0.79%
+198.5%
Q2 2018$12,550,000
+49.5%
13,000,000
+66.0%
0.26%
+60.0%
Q1 2018$8,394,000
+30.0%
7,829,000
+20.4%
0.16%
+33.1%
Q4 2017$6,457,000
+1.5%
6,500,0000.0%0.12%
+3.3%
Q3 2017$6,359,000
-32.0%
6,500,000
-36.6%
0.12%
-33.0%
Q2 2017$9,357,000
-18.0%
10,250,000
-14.6%
0.18%
-16.0%
Q1 2017$11,410,000
+106.2%
12,000,000
+84.6%
0.21%
+108.8%
Q4 2016$5,533,000
-7.6%
6,500,000
-8.5%
0.10%
+17.2%
Q3 2016$5,985,000
+4.9%
7,100,0000.0%0.09%
-1.1%
Q2 2016$5,705,000
+10.1%
7,100,000
+9.2%
0.09%
+11.4%
Q1 2016$5,180,000
-40.5%
6,500,000
-42.6%
0.08%
-41.0%
Q4 2015$8,710,000
-23.9%
11,327,000
-33.9%
0.13%
-23.4%
Q3 2015$11,447,000
-58.6%
17,131,000
-41.2%
0.18%
-56.0%
Q2 2015$27,644,000
+9.8%
29,131,000
-1.1%
0.40%
+9.3%
Q1 2015$25,167,000
+41.1%
29,453,000
+29.8%
0.36%
+38.9%
Q4 2014$17,830,000
-9.5%
22,692,000
+8.7%
0.26%
-13.8%
Q3 2014$19,706,000
-10.1%
20,876,000
-6.2%
0.30%
-7.0%
Q2 2014$21,925,000
-36.1%
22,267,000
-15.7%
0.33%
-39.0%
Q1 2014$34,312,000
-17.2%
26,409,000
-7.1%
0.54%
+2.9%
Q4 2013$41,428,000
+37.8%
28,424,000
+54.5%
0.52%
+29.0%
Q3 2013$30,062,000
+31.2%
18,398,000
+23.9%
0.40%
+12.2%
Q2 2013$22,916,00014,844,0000.36%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 4,233,000$4,227,9204.38%
Monashee Investment Management LLC 4,000,000$4,034,3941.74%
Radcliffe Capital Management, L.P. 27,688,000$27,654,7740.88%
OAKTREE CAPITAL MANAGEMENT LP 19,354,000$19,403,3530.20%
WOLVERINE ASSET MANAGEMENT LLC 14,676,000$14,631,6300.15%
SSI INVESTMENT MANAGEMENT LLC 2,275,000$2,272,2700.14%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 2,870,000$2,8670.02%
D. E. Shaw & Co., Inc. 11,336,000$11,304,6850.01%
Russell Investments Group, Ltd. 4,171,000$4,211,0600.01%
TORONTO DOMINION BANK 2,450,000$2,4420.00%
View complete list of THERAVANCE INC shareholders